Healthcare -
Biotechnology - NASDAQ - US
$ 14.13
-4.33 %
$ 1.44 B
Market Cap
-3.95
P/E
DYN - CASH & EQUIVALENTS
Cash & Equivalents DYN - Dyne Therapeutics, Inc.
122 M
LAST VALUE
-22.18%
2 YEAR CAGR
71.81%
5 YEAR CAGR
-17.60%
10 YEAR CAGR